Viking Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '25 Dec 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	3,359	4,331	1,684	675	316	336	Upgrade
Market Cap Growth	-42.10%	157.18%	149.68%	113.16%	-5.75%	-34.98%	Upgrade
Enterprise Value	2,745	3,434	1,345	531	126	127	Upgrade
Last Close Price	31.51	38.24	17.32	8.56	4.07	4.70	Upgrade
PB Ratio	5.53	5.09	5.34	4.96	1.78	1.68	Upgrade
P/TBV Ratio	5.53	5.09	5.34	4.96	1.78	1.68	Upgrade
Debt / Equity Ratio	0.00	0.00	0.00	0.01	0	0.00	Upgrade
Quick Ratio	27.41	32.93	18.92	7.09	23.02	20.48	Upgrade
Current Ratio	28.34	33.09	19.19	7.61	23.98	21.12	Upgrade
Return on Equity (ROE)	-29.23%	-17.90%	-34.79%	-39.67%	-24.65%	-15.15%	Upgrade
Return on Assets (ROA)	-20.48%	-14.77%	-23.47%	-23.19%	-14.90%	-9.86%	Upgrade
Return on Capital (ROIC)	-21.12%	-15.32%	-25.38%	-25.21%	-15.58%	-10.21%	Upgrade
Return on Capital Employed (ROCE)	-38.50%	-17.10%	-28.90%	-48.00%	-27.60%	-17.50%	Upgrade
Earnings Yield	-6.02%	-2.45%	-4.61%	-9.55%	-15.28%	-9.62%	Upgrade
Buyback Yield / Dilution	-5.48%	-15.57%	-22.79%	0.47%	-6.34%	-0.89%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.